DUBLIN, Ireland--(BUSINESS WIRE)--The life sciences sector in Ireland continues to thrive, both with indigenous and overseas companies. Ireland is now in a leadership position in many key business segments. In bio-pharmaceuticals, Eli Lilly joined Schering Plough, Wyeth, Genzyme and Centocor in making Ireland the location of choice outside the US for the development and manufacture of their newest drugs. Continued growth in the medical technologies was evident from recent new investment announcements from Kinetic Concepts Inc., Teleflex Medical and Integra Lifesciences in addition to further investments from Merck, Wyeth, Baxter and Genzyme following key investments in 2006 from Cordis, USCI and Vistakon, among others.
